Osteogenesis Imperfecta

Medications for Osteogenesis Imperfecta

Other names: Brittle bone disease

About Osteogenesis Imperfecta: Osteogenesis imperfecta is a condition inducing exceptionally fragile bones.

The following set of medications have been found at the treatment of this illness, or in some way related to.

Drug title	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Miacalcin	Rx	C	N	Insert review	0.0
Generic title: calcitonin systemic Drug course: calcitonin For consumers: dosage, interactions, side effects For specialists: Prescribing Information

calcitonin	Rx	C	N	Insert review	0.0
Generic title: calcitonin systemic Brand title: Miacalcin Drug course: calcitonin For consumers: dosage, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information

Rx	Prescription-only
OTC	On The Counter
Rx/OTC	Prescription or Over The Counter
Off Label	This drug may not be approved by the FDA for the treatment of this particular condition.

Pregnancy Category
A	sufficient and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters).
B	Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C	Animal research studies have demonstrated a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D	there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify use in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in pregnant women obviously outweigh potential gains.
N	FDA has not classified the medication.

Controlled Substances Act (CSA) Program
N	Is not at the mercy of the Controlled Substances Act.
1	includes a higher possibility of abuse. Has no currently accepted medical use in treatment in the USA. There is just a lack of accepted safety for use under medical supervision.
Two	includes a higher possibility of abuse. Features a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Psychotherapy can cause acute physical or psychological dependence.
3	includes a possibility for abuse less than people in schedules 1 and 2. Features a currently accepted medical use in treatment in the USA. Psychotherapy can lead to physical dependence or high psychological dependence.
4	includes a very low potential for abuse relative to people in schedule 3. It has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence relative to people in schedule 3.
5	includes a very low potential for abuse relative to people in schedule 4. Features a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence relative to people in schedule 4.

Infection
X	Interacts with Alcohol.

Always seek advice from your healthcare provider to be sure the information displayed on these pages applies to your circumstances.